Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

Research ArticleNeurointervention

Percutaneous Transluminal Angioplasty and Stenting of the Proximal Vertebral Artery for Symptomatic Stenosis

Michel Piotin, Laurent Spelle, Jean-Baptiste Martin, Alain Weill, Gérald Rancurel, Ian B. Ross, Daniel A. Rüfenacht and Jacques Chiras
American Journal of Neuroradiology April 2000, 21 (4) 727-731;
Michel Piotin
aFrom the Department of Neuroradiology Charcot (M.P., L.S., A.W., J.C.), Hôpital de la Salpêtrière, Paris, France; the Department of Radiology (J.-B.M., D.A.R.), Section of Neuroradiology, Geneva University Hospital, Switzerland; the Department of Neurology (G.R.), Hôpital de la Salpêtrière, Paris, France; and the Department of Neurosurgery (I.B.R.), Saint Boniface General Hospital, Winnipeg, Manitoba, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurent Spelle
aFrom the Department of Neuroradiology Charcot (M.P., L.S., A.W., J.C.), Hôpital de la Salpêtrière, Paris, France; the Department of Radiology (J.-B.M., D.A.R.), Section of Neuroradiology, Geneva University Hospital, Switzerland; the Department of Neurology (G.R.), Hôpital de la Salpêtrière, Paris, France; and the Department of Neurosurgery (I.B.R.), Saint Boniface General Hospital, Winnipeg, Manitoba, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Baptiste Martin
aFrom the Department of Neuroradiology Charcot (M.P., L.S., A.W., J.C.), Hôpital de la Salpêtrière, Paris, France; the Department of Radiology (J.-B.M., D.A.R.), Section of Neuroradiology, Geneva University Hospital, Switzerland; the Department of Neurology (G.R.), Hôpital de la Salpêtrière, Paris, France; and the Department of Neurosurgery (I.B.R.), Saint Boniface General Hospital, Winnipeg, Manitoba, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alain Weill
aFrom the Department of Neuroradiology Charcot (M.P., L.S., A.W., J.C.), Hôpital de la Salpêtrière, Paris, France; the Department of Radiology (J.-B.M., D.A.R.), Section of Neuroradiology, Geneva University Hospital, Switzerland; the Department of Neurology (G.R.), Hôpital de la Salpêtrière, Paris, France; and the Department of Neurosurgery (I.B.R.), Saint Boniface General Hospital, Winnipeg, Manitoba, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gérald Rancurel
aFrom the Department of Neuroradiology Charcot (M.P., L.S., A.W., J.C.), Hôpital de la Salpêtrière, Paris, France; the Department of Radiology (J.-B.M., D.A.R.), Section of Neuroradiology, Geneva University Hospital, Switzerland; the Department of Neurology (G.R.), Hôpital de la Salpêtrière, Paris, France; and the Department of Neurosurgery (I.B.R.), Saint Boniface General Hospital, Winnipeg, Manitoba, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ian B. Ross
aFrom the Department of Neuroradiology Charcot (M.P., L.S., A.W., J.C.), Hôpital de la Salpêtrière, Paris, France; the Department of Radiology (J.-B.M., D.A.R.), Section of Neuroradiology, Geneva University Hospital, Switzerland; the Department of Neurology (G.R.), Hôpital de la Salpêtrière, Paris, France; and the Department of Neurosurgery (I.B.R.), Saint Boniface General Hospital, Winnipeg, Manitoba, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel A. Rüfenacht
aFrom the Department of Neuroradiology Charcot (M.P., L.S., A.W., J.C.), Hôpital de la Salpêtrière, Paris, France; the Department of Radiology (J.-B.M., D.A.R.), Section of Neuroradiology, Geneva University Hospital, Switzerland; the Department of Neurology (G.R.), Hôpital de la Salpêtrière, Paris, France; and the Department of Neurosurgery (I.B.R.), Saint Boniface General Hospital, Winnipeg, Manitoba, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacques Chiras
aFrom the Department of Neuroradiology Charcot (M.P., L.S., A.W., J.C.), Hôpital de la Salpêtrière, Paris, France; the Department of Radiology (J.-B.M., D.A.R.), Section of Neuroradiology, Geneva University Hospital, Switzerland; the Department of Neurology (G.R.), Hôpital de la Salpêtrière, Paris, France; and the Department of Neurosurgery (I.B.R.), Saint Boniface General Hospital, Winnipeg, Manitoba, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

Abstract

BACKGROUND AND PURPOSE: Percutaneous transluminal angioplasty (PTA) for significant stenosis involving the origin of the vertebral artery is now a well established treatment for selected patients when posterior cerebral arterial circulation is compromised. Arterial spasm, dissection, and restenosis may occur in some instances, with subsequent hemodynamic compromise. To prevent these potential complications, we combined PTA of the vertebral artery with primary stenting, using coronary stents, in seven patients. We herein present our short- and intermediate-term results.

METHODS: A total of seven lesions affecting the origin of the vertebral artery were treated by primary trans-stenotic coronary stent placement. All patients were symptomatic, fulfilling the general criteria for vertebral artery angioplasty. Patients were followed for up to 36 months after treatment.

RESULTS: All seven lesions were successfully dilated. Residual stenosis was never greater than 20% in diameter. No perioperative complications occurred. Clinical follow-up showed immediate resolution or improvement of symptoms in all patients. One patient's condition deteriorated 15 months after stent placement because of atheromatous stenosis of the prevertebral segment in the ipsilateral subclavian artery.

CONCLUSION: Stent placement to treat significant stenosis involving the origin of the vertebral artery is safe and effective for alleviating symptoms and improving blood flow to the posterior cerebral circulation. Coronary stent design seems to be particularly well suited to cover atherosclerotic lesions of the origin of the vertebral artery. The stent mesh probably prevents elastic recoil and early restenosis after PTA, as it does in coronary arteries.

Obstructive lesions of the vertebral arteries may cause symptoms of vertebrobasilar insufficiency. Although these are often ignored, symptomatic atherosclerotic stenosis involving this circulation will often respond to percutaneous transluminal angioplasty (PTA). There has been some reluctance in the endovascular community to be aggressive with these lesions, partly because of concerns regarding early or late restenosis of atherosclerotic lesions. Technical complications include arterial spasm and intimal dissection with potential subsequent hemodynamic compromise in the posterior circulation. There are, however, real potential benefits to the patient in terms of symptom resolution. We report our initial results and follow-up of proximal vertebral angioplasty and stenting for the treatment of symptomatic atherosclerotic stenoses.

Methods

Seven patients (six male and one female patient; mean age, 68 years) underwent vertebral angioplasty and stenting using balloon-expandable coronary stents (Figs 1 and 2). All lesions were located at the origin of the vertebral artery (three right, four left).

fig 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
fig 1.

Patient 1.

A, Angiogram of the left subclavian artery shows subocclusive stenosis of the left vertebral artery ostium (arrow).

B, Plain radiograph shows the Palmaz-Schatz stent (arrow) after its delivery. Considering plaque calcifications (arrowheads) as the boundary of the left subclavian artery, the stent is slightly protruding into the subclavian artery lumen.

C, Final control angiogram of the left subclavian artery shows excellent antegrade filling of the left vertebral artery. The prevertebral segment of the subclavian artery is severely diseased (filled arrow). The distal segment of the subclavian artery is chronically occluded. A scapular artery facilitates the arterial circulation of the patient's left arm (open arrow). The patient was doing well at the 3-year follow-up visit.

fig 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
fig 2.

Patient 6.

A, High-grade stenosis of the origin of the left vertebral artery (arrow).

B, Post stenting angiogram (NIR Primo stent) of the left subclavian artery shows excellent antegrade filling of the left vertebral artery. The patient was doing well at the 18-month follow-up visit.

Clinical Evaluation and Indication for PTA

Our population had a wide variety of symptoms of posterior fossa and posterior cerebral ischemia. Symptoms were refractory to medical therapy, including antiplatelet and anticoagulant medication, in all patients. The Table summarizes the patients' clinical data.

View this table:
  • View inline
  • View popup
  • Download powerpoint

Clinical data, cross-sectional imaging and angiographic results

Radiologic Evaluation

CT or MR imaging of the brain was performed before digital subtraction angiography. One patient underwent an hexametazime single-photon emission CT brain study. This showed cerebellar hypoperfusion. Aortic arch angiography and four-vessel digital subtraction angiography were performed to evaluate extra- and intracranial arteries in all patients. Special attention was paid to the subclavian and vertebral arteries and to the collateral blood flow to posterior cerebral circulation. Vertebral artery stenosis was considered to be angiographically significant when greater than 70%, but only if the other vertebral artery was equally diseased or absent. The angiographic appearance of the atherosclerotic vertebral lesions in this series was uniform, showing smooth luminal stenosis without plaque ulceration at the origin of the vessel. There was no evidence of distal vertebral or basilar artery stenosis in any patient.

PTA and Stent Implantation

In all except one case, therapeutic procedures were performed during a second angiographic session. In six cases, the endovascular approach was performed via a transfemoral route with the patients under local anesthesia. In one case, a brachial approach was preferred because proximal vessel tortuosity made access too difficult via a transfemoral route.

After arterial puncture, a 7F sheath was inserted and systemic anticoagulation was achieved with IV administered heparin (5000 IU) and aspirin (250 mg). A 7F guiding catheter was then navigated into the subclavian artery, and an “angiographic roadmap” was made of the subclavian and the vertebral arteries. The narrowed arterial segment was then crossed with a 160-cm-long 0.014-inch guidewire (Transend 14; Scimed, Maplegrove, MA) that was navigated into the normal distal cervical vertebral artery. The PTA balloon catheter, with the crimped stent, was then placed over the guidewire and directed across the lesion site. The balloon was inflated up to the maximum recommended pressure to deploy and impact the stent into the inner arterial wall. Balloon inflation never lasted longer than 20 to 30 seconds.

The vertebral arteries in our patients had diameters of 3 to 5 mm, which is a caliber similar to that of coronary arteries. In the first two cases, we used Palmaz-Schatz (Johnson and Johnson, Warren, NJ) and NIR (Boston Scientific Corporation, Natick, MA) coronary stents that were manually crimped on a 5-mm-diameter coronary balloon catheter (Viva, Boston Scientific Corporation). In the five remaining cases, we used premounted NIR stents (NIR PRIMO; Boston Scientific Corporation). These allowed for easy navigation across the stenotic arterial segment and immediate, rapid, and accurate stent placement without the use of balloon predilation.

Post-PTA Medical Regimen and Follow-up

Immediately after stent placement, digital subtraction angiography was performed to assess the treated vessel. Careful attention was also paid to the intracranial circulation to rule out any sign of distal embolization. Patients were discharged from the neurologic ward 2 to 7 days (mean, 4 days) after the procedure, when their neurologic condition was determined to be stable. They received 500 mg of ticlopidine daily (Ticlid; Sanofi Winthrop, Gentilly, France) for at least 3 months after PTA. The follow-up duration ranged from 4 to 36 months (mean, 15 months) after stent implantation. Duplex Doppler sonography was used during the follow-up period to assess stent patency.

Results

The seven patients presented with acute (two cases) or chronic (five cases) vertebrobasilar insufficiency attributable to severe stenoses at the origin of the dominant vertebral artery, with contralateral vertebral artery flow impairment from vertebral hypoplasia, stenosis, or occlusion. The symptoms resolved in all patients after endovascular treatment. In no case was the residual stenosis greater than 20% nor were there signs of distal embolization on the immediate control angiograms. No transient or permanent neurologic deficits occurred.

Only one patient had a recurrence of his referring symptoms (patient 3). Duplex Doppler follow-up in this case disclosed stenosis of the left subclavian artery. Digital subtraction angiography confirmed the presence of an atheromatous stenosis of the prevertebral segment of the ipsilateral subclavian artery without any restenosis of the stented origin of the vertebral artery. The six other patients, who did well, had no sonographic evidence of restenosis.

Discussion

Patient Selection for Vertebral PTA

Symptomatic posterior circulation atheromatous lesions are now treatable by an endovascular approach (1). PTA of the vertebral artery may be indicated when vertebral arterial flow–obstructing lesions are found in patients with brain stem ischemia (2). Our patients presented with symptoms suggesting vertebrobasilar insufficiency, such as vestibular ataxia, vegetative disturbance (presyncopal episode), nausea, gait disturbance, and drop attacks (Table). The combination of symptoms made the diagnosis of posterior fossa ischemia almost pathognomonic. Medical therapy (anticoagulation) failed to resolve the symptoms, and endovascular revascularization (PTA and stenting) was prompted. The majority of patients with symptoms of posterior cerebral circulation ischemia, however, can be managed by conservative treatment, including anticoagulation and antiplatelet medication (3). Most patients tolerate occlusion of one vertebral artery because there is usually sufficient blood perfusion from the contralateral side. For patients presenting with bilateral vertebral stenosis who are refractory to medical treatment, PTA is a viable alternative to surgery. The goals are to improve blood flow to the posterior cerebral circulation and to reduce the risk of distal embolization (4).

Exhaustive angiography of both the posterior and anterior cerebral circulations is required before performing angioplasty. Special attention must be paid to collateral supply from the contralateral vertebral artery, as well as the external carotid artery, from which collaterals may restitute the distal vertebral artery in cases of vertebral occlusion or severe stenosis. Also, patients may have excellent filling of the posterior circulation via the posterior communicating arteries and may tolerate stenosis of one or both vertebral arteries. Considering these possibilities for collateral blood flow, it is not surprising that lesions in the vertebrobasilar system are often asymptomatic and that only the minority of patients will benefit from treatment.

PTA and Stenting of the Proximal Vertebral Artery

There have been reports of the use of PTA to treat proximal vertebral artery stenosis (1, 5–10). PTA is now a well established therapeutic alternative to operative reconstruction of proximal vertebral artery stenoses and seems to be relatively safe. No mortality has been reported after PTA. Spasm, immediate occlusion secondary to dissection, and long-term restenosis may occur after PTA. These may be asymptomatic or may lead to transient or permanent neurologic complications. Higashida et al (1) reported that 8.8% of their patients had transient neurologic complications after PTA of the proximal vertebral artery. In this series of 34 patients who underwent angioplasty without stenting, the restenosis rate was 8.8% (three patients, two of whom were symptomatic). The cases of restenoses were successfully treated with repeat balloon angioplasty. Bruckman et al (5) reported a restenosis rate of 15% after proximal vertebral artery PTA, again without stenting. Storey et al (11) implanted stents in the proximal vertebral artery in two patients to treat symptomatic restenosis. This resulted in immediate reversal of stenosis and resolution of symptoms in both patients (11). Angiographic follow-up at 1 year showed continued patency of vertebral artery lumina. Feldman et al (12) reported the case of a patient presenting with bilateral proximal vertebral artery stenoses. These lesions were treated with Palmaz-Schatz coronary stents immediately after balloon angioplasty alone failed to achieve a good anatomic result (12).

Repeat angioplasty with stent placement may be a solution to treat immediate or delayed restenosis, but primary stent placement, as it was performed in our series, may obviate the need for repeat angioplasty. Distal embolization in the cerebral circulation is always a major concern when treating diseased vessels of the cerebral circulation. Stent placement may lower the potential for embolism by smoothing luminal irregularities, decreasing turbulence, and increasing flow. Furthermore, fibrous tissue and neointimal growth over the stent mesh has been shown to cover atheromatous tissue in experimental models, thereby lowering the risk for thrombus formation and further distal embolization (13). Also, significantly lower incidence of restenosis has been shown in coronary arteries of patients after the placement of stents greater than 3 mm in diameter (14). Patients in our series underwent stent placement in vessels of 3 to 5 mm in diameter, which is a caliber similar to that of coronary arteries. Coronary stent flexibility allowed for ease of tracking along vessel tortuosity, especially when a brachial approach was used.

Conclusion

Restenosis after angioplasty without stenting is a cause of midterm failure of vertebral angioplasty in atherosclerotic disease. Primary reinforcement of the vessel wall with a stent may improve the immediate and long-term outcomes of proximal vertebral artery PTA. Premounted coronary-designed stent systems are ideal for symptomatic atheromatous stenoses in the vertebral arterial circulation. They allow for one-step angioplasty and stent placement, avoiding the need of primary balloon dilation.

Footnotes

  • ↵1 Address reprint requests to Michel Piotin, MD, 4 rue Euryale Dehaynin, 75019 Paris, France.

References

  1. ↵
    Higashida RT, Tsai FY, Halbach VV, et al. Transluminal angioplasty for atherosclerotic disease of the vertebral and basilar arteries. J Neurosurg 1993;78:192-198
    CrossRefPubMed
  2. ↵
    Imparato AM, Riles TS, Kim GE. Cervical vertebral angioplasty for brain stem ischemia. Surgery 1981;90:842-852
    PubMed
  3. ↵
    International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 1997;349:1569-1581
    CrossRefPubMed
  4. ↵
    George B, Laurian C. Vertebro-basilar ischaemia: its relation to stenosis and occlusion of the vertebral artery. Acta Neurochir (Wien) 1982;62:287-295
    CrossRefPubMed
  5. ↵
    Bruckmann H, Ringelstein EB, Buchner H, Zeumer H. Percutaneous transluminal angioplasty of the vertebral artery: a therapeutic alternative to operative reconstruction of proximal vertebral artery stenoses. J Neurol 1986;233:336-339
    CrossRefPubMed
  6. Courtheoux F, Tournade A, Théron J. Transcutaneous angioplasty of vertebral artery atheromatous ostial stricture. Neuroradiology 1985;27:259-264
    CrossRefPubMed
  7. Higashida RT, Hieshima GB, Tsai FY, Bentson JR, Halbach VV. Percutaneous transluminal angioplasty of the subclavian and vertebral arteries. Acta Radiol Suppl 1986;369:124-126
    PubMed
  8. Higashida RT, Hieshima GB, Tsai FY, Halbach VV, Norman D, Newton TH. Transluminal angioplasty of the vertebral and basilar artery. AJNR Am J Neuroradiol 1987;8:745-749
    Abstract/FREE Full Text
  9. Kachel R, Endert G, Basche S, Grossmann K, Glaser FH. Percutaneous transluminal angioplasty (dilatation) of carotid, vertebral, and innominate artery stenoses. Cardiovasc Intervent Radiol 1987;10:142-146
    CrossRefPubMed
  10. Kachel R. Percutaneous transluminal angioplasty (PTA) of supra-aortic arteries especially of the carotid and vertebral artery: an alternative to vascular surgery? J Mal Vasc 1993;18:254-257
    PubMed
  11. ↵
    Storey GS, Marks MP, Dake M, Norbash AM, Steinberg GK. Vertebral artery stenting following percutaneous transluminal angioplasty. J Neurosurg 1996;84:883-887
    CrossRefPubMed
  12. ↵
    Feldman RL, Rubin JJ, Kuykendall RC. Use of coronary Palmaz-Schatz stent in the percutaneous treatment of vertebral artery stenoses. Cathet Cardiovasc Diagn 1996;38:312-315
    CrossRefPubMed
  13. ↵
    Wakhloo AK, Tio FO, Lieber BB, Schellhammer F, Graf M, Hopkins N. Self-expanding nitinol stents in canine vertebral arteries: hemodynamics and tissue response. AJNR Am J Neuroradiol 1995;16:1043-1051
    Abstract
  14. ↵
    Roubin GS, Cannon AD, Agrawal SK, et al. Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation 1992;85:916-927
    Abstract/FREE Full Text
  • Received March 23, 1999.
  • Copyright © American Society of Neuroradiology
View Abstract
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology
Vol. 21, Issue 4
1 Apr 2000
  • Table of Contents
  • Index by author
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Percutaneous Transluminal Angioplasty and Stenting of the Proximal Vertebral Artery for Symptomatic Stenosis
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
Michel Piotin, Laurent Spelle, Jean-Baptiste Martin, Alain Weill, Gérald Rancurel, Ian B. Ross, Daniel A. Rüfenacht, Jacques Chiras
Percutaneous Transluminal Angioplasty and Stenting of the Proximal Vertebral Artery for Symptomatic Stenosis
American Journal of Neuroradiology Apr 2000, 21 (4) 727-731;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
Percutaneous Transluminal Angioplasty and Stenting of the Proximal Vertebral Artery for Symptomatic Stenosis
Michel Piotin, Laurent Spelle, Jean-Baptiste Martin, Alain Weill, Gérald Rancurel, Ian B. Ross, Daniel A. Rüfenacht, Jacques Chiras
American Journal of Neuroradiology Apr 2000, 21 (4) 727-731;
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Lesion location, stability, and pretreatment management: factors affecting outcomes of endovascular treatment for vertebrobasilar atherosclerosis
  • A Systematic Review of Stenting and Angioplasty of Symptomatic Extracranial Vertebral Artery Stenosis
  • Doppler Criteria for Identifying Proximal Vertebral Artery Stenosis of 50% or More
  • Long-Term Outcome After Angioplasty and Stenting for Symptomatic Vertebral Artery Stenosis Compared With Medical Treatment in the Carotid And Vertebral Artery Transluminal Angioplasty Study (CAVATAS): A Randomized Trial
  • Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline.
  • Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline.
  • Vertebral artery origin angioplasty and primary stenting: safety and restenosis rates in a prospective series
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • Flow diversion for distal circulation aneurysms
  • Neuroform Atlas Stent for Intracranial Aneurysms
  • Transophthalmic Artery Embolization of Meningiomas
Show more Neurointervention

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner
  • Book Reviews

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire